Endpoints News 生物医药· Ayisha Sharma·· 2026-10-14AI 评分39
Zealand Pharma 签约最高 13 亿美元交易,利用 AI 技术设计肥胖及代谢疾病蛋白质疗法
Zealand inks up to $1.3B deal for AI-designed obesity treatments
AI 导读
Zealand Pharma 宣布利用 Generate Biomedicines 的 AI 技术开发基于蛋白质的肥胖及其他代谢疾病疗法,交易金额最高达 13 亿美元。
正文
Zealand Pharma said Tuesday it will develop new protein-based treatments for obesity and other metabolic diseases with the help of Generate Biomedicines’ AI technology.
The …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news